Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- Check6 days agoChange DetectedThe Locations section was expanded with numerous new sites across the United States, Argentina, Australia, and various countries in Europe and beyond. Many regional locations were added to reflect broader geographic coverage.SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a citation for the 2025 Rheumatology Therapeutics article '196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2' (Dec 2025). Replaced the 'Online ahead of print' note with the finalized 2025 publication details.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded publication Gossec L., et al., 'Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naive patients in two phase 3 clinical trials' (Arthritis Res Ther. 2025) and updated the revision to v3.3.2; removed v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded clarifications that publications are provided voluntarily by the study submitter and may be drawn from PubMed, and that entries may not all pertain to the study. Updated the revision version to v3.3.1.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedThe screenshots show only formatting/layout adjustments and the location list; no core study information or criteria appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.